Psychedelic-Assisted Psychotherapy
Cambridge University Press eBooks May 28, 2021 DOI: 10.1017/9781108686976.030 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Interventions | MDMA psilocybin LSD |
| Topics | Psilocybin Psychedelic-assisted therapy |
| Keywords | Psychotherapist Subject documents Hallucinogen Library science |
| Citations | 2 |
| Key findings | Psychedelic-assisted psychotherapy appears to be moving from a fringe subject to a significant new treatment method for psychiatric disorders that have traditionally been hard to treat. |
Abstract
In recent years there has been a resumption of research into the potential therapeutic benefits of psychedelic1 drugs such as MDMA2, psilocybin and LSD3. Clinical research suggests significant efficacy for psychiatric disorders that have traditionally been hard to treat. The evidence base has accumulated to the point that psychedelic-assisted psychotherapy appears to be moving from a fringe subject to a significant new treatment method that all psychotherapists should at least be aware of and that some may develop into a special interest.
Comparable studies
Other narrative reviews on psilocybin and psychedelic-assisted therapy, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development | 2018 | Review | |
| Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. | 2016 | Review | |
| Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy | 2021 | Systematized review | |
| The Emerging Field of Psychedelic Psychotherapy. | 2022 | Review | |
| Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications Participants in psychedelic therapy research aged 18–69 with varied backgrounds | 2020 | Rapid review | n = 180 |